AMIX Autonomix Medical, Inc. Common Stock
USHealthcareAs of 2026-07-10 12:35
Why AMIX matters now
Autonomix Medical, Inc. Common Stock (AMIX) is a US stock in Healthcare. The latest InvestLog snapshot shows $6.58 with +1.86% on the session and $3.6M in market capitalization; recent performance reads 1-month +28.42% and YTD -33.78%.
The latest financial table shown here is Q4 2026, with revenue of $0.00, net income of $-2.7M, and EPS of $-0.23. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -594.5%.
The latest indexable market news headline is "Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $—. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
4.46
P/S
0.00
EV/EBITDA
0.31
DCF Value
$0.09
FCF Yield
-594.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-239.4%
ROA
-219.9%
ROIC
-289.0%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2026 | $0.00 | $-2.7M | $-0.23 |
| FY 2026 | $0.00 | $-16.7M | $-2.32 |
| Q3 2026 | $0.00 | $-3.3M | $-0.36 |
| Q2 2026 | $0.00 | $-7.5M | $-1.38 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
-1.41
Autonomix Medical, Inc. is an emerging medical device company focused on developing advanced solutions for identifying and treating various disorders impacting the peripheral nervous system. At the core of its innovation is a sophisticated technology platform that incorporates a catheter-based, microchip-enabled sensing array, engineered to precisely detect and differentiate peripheral neural signals. This Texas-based firm, headquartered in The Woodlands, was established in 2014.